-+ 0.00%
-+ 0.00%
-+ 0.00%

Alnylam Pharmaceuticals Price Target Raised to $400.00/Share From $370.00 by Morgan Stanley

Dow Jones·07/10/2026 13:56:00

Please log in to view news